Table 9.
MHC pre-mRNA
| Variable | Men |
Women |
Training Effect | Sex Effect | Interaction Effect | ||
|---|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | ||||
| Type I pre-mRNA | 27.8 ± 3.8 | 32.5 ± 4.8 | 37.1 ± 5.2 | 37.3 ± 4.6 |
F1,19 = 0.433 n.s. |
F1,19 = 2.501 n.s. |
F1,19 = 0.286 n.s. |
| IIa pre-mRNA | 46.5 ± 4.0 | 52.5 ± 5.7 | 42.8 ± 4.4 | 49.1 ± 2.4 |
F1,17 = 8.986 P = 0.0081 |
F1,17 = 0.0874 n.s. |
F1,17 = 3.505 n.s. |
| IIx pre-mRNA | 21.5 ± 3.3 | 12.9 ± 2.0 | 11.0 ± 1.6 | 12.6 ± 1.2 |
F1,19 = 3.224 n.s. (P = 0.088) |
F1,19 = 1.271 n.s. |
F1,19 = 14.138 P = 0.0013 |
| IIb pre-mRNA | 8.3 ± 2.0 | 14.2 ± 2.8 | 5.9 ± 1.7 | 13.8 ± 4.1 |
F1,19 = 8.931 P = 0.0076 |
F1,19 = 0.367 n.s. |
F1,19 = 0.694 n.s. |
Data are means ± SE in arbitrary units/mg muscle. MHC, myosin heavy chain. Statistical significance was determined by repeated measures ANOVA and is reported for P < 0.05; n.s., not significant.